BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND AKT1, P31749, RAC-ALPHA, RAC, PRKBA, PKB-ALPHA, PKB, MGC99656, AKT, ENSG00000142208, 207
2485 results:

  • 1. Blocking the MIF-CD74 axis augments radiotherapy efficacy for brain metastasis in NSCLC via synergistically promoting microglia M1 polarization.
    Liu L; Wang J; Wang Y; Chen L; Peng L; Bin Y; Ding P; Zhang R; Tong F; Dong X
    J Exp Clin Cancer Res; 2024 Apr; 43(1):128. PubMed ID: 38685050
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Multi-Omics Pan-cancer Analysis of Procollagen N-Propeptidase Gene Family of ADAMTS as Novel Biomarkers to Associate with Prognosis, Tumor Immune Microenvironment, Signaling Pathways, and Drug Sensitivities.
    Chen Y; Xiao C; Fan Q; Zhang Y; Huang Q; Ou Y
    Front Biosci (Landmark Ed); 2024 Apr; 29(4):151. PubMed ID: 38682182
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. LncRNA NDUFA6-DT: A Comprehensive Analysis of a Potential LncRNA Biomarker and Its Regulatory Mechanisms in Gliomas.
    Huang R; Kong Y; Luo Z; Li Q
    Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674418
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Personalized identification and characterization of genome-wide gene expression differences between patient-matched intracranial and extracranial melanoma metastasis pairs.
    Kraft T; Grützmann K; Meinhardt M; Meier F; Westphal D; Seifert M
    Acta Neuropathol Commun; 2024 Apr; 12(1):67. PubMed ID: 38671536
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Expression of STAT3 and hypoxia markers in long-term surviving malignant glioma patients.
    Dvorakova K; Skarkova V; Vitovcova B; Soukup J; Vosmikova H; Pleskacova Z; Skarka A; Bartos MC; Krupa P; Kasparova P; Petera J; Rudolf E
    BMC Cancer; 2024 Apr; 24(1):509. PubMed ID: 38654280
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Lactoferrin mediates epithelial-mesenchymal transformation by regulating the PI3K/akt/mTOR pathway to inhibit nasopharyngeal carcinoma metastasis.
    Xu M; Fan Y; Zou G; Yang Q; Xu F
    Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):130-135. PubMed ID: 38650146
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Identification of core genes of craniopharyngioma angiogenesis based on single-cell nuclear transcriptome sequencing.
    Zhang J; Xu L; Ye J; Xu C; Wu B; Wu J; Hong T
    Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):136-141. PubMed ID: 38650143
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Multi-omics technologies and molecular biomarkers in brain tumor-related epilepsy.
    Du Y; Li R; Fu D; Zhang B; Cui A; Shao Y; Lai Z; Chen R; Chen B; Wang Z; Zhang W; Chu L
    CNS Neurosci Ther; 2024 Apr; 30(4):e14717. PubMed ID: 38641945
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Transient receptor potential vanilloid-1 (TRPV1) channels act as suppressors of the growth of glioma.
    Cheng J; Zeng M; Peng B; Li P; Zhao S
    Brain Res Bull; 2024 Jun; 211():110950. PubMed ID: 38631651
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Central neurocytoma exhibits radial glial cell signatures with FGFR3 hypomethylation and overexpression.
    Lee Y; Chowdhury T; Kim S; Yu HJ; Kim KM; Kang H; Kim MS; Kim JW; Kim YH; Ji SY; Hwang K; Han JH; Hwang J; Yoo SK; Lee KS; Choe G; Won JK; Park SH; Lee YK; Shin JH; Park CK; Kim CY; Kim JI
    Exp Mol Med; 2024 Apr; 56(4):975-986. PubMed ID: 38609519
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Haploinsufficiency of phosphodiesterase 10A activates PI3K/akt signaling independent of PTEN to induce an aggressive glioma phenotype.
    Nuechterlein N; Shelbourn A; Szulzewsky F; Arora S; Casad M; Pattwell S; Merino-Galan L; Sulman E; Arowa S; Alvinez N; Jung M; Brown D; Tang K; Jackson S; Stoica S; Chittaboina P; Banasavadi-Siddegowda YK; Wirsching HG; Stella N; Shapiro L; Paddison P; Patel AP; Gilbert MR; Abdullaev Z; Aldape K; Pratt D; Holland EC; Cimino PJ
    Genes Dev; 2024 Apr; 38(5-6):273-288. PubMed ID: 38589034
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Meningioma: current updates on genetics, classification, and mouse modeling.
    Szulzewsky F; Thirimanne HN; Holland EC
    Ups J Med Sci; 2024; 129():. PubMed ID: 38571886
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. IQGAP3 promotes the progression of glioma as an immune and prognostic marker.
    Gao X; Ge J; Gao X; Mei NA; Su Y; Shan S; Qian W; Guan J; Zhang Z; Wang L
    Oncol Res; 2024; 32(4):659-678. PubMed ID: 38560572
    [No Abstract]    [Full Text] [Related]  

  • 14. Regulation of inflammatory response by LINC00346 via miR-25-3p-mediated modulation of the PTEN/PI3K/akt/NF-κB pathway.
    Kim MJ; Lim SG; Cho DH; Lee JY; Suk K; Lee WH
    Biochem Biophys Res Commun; 2024 May; 709():149828. PubMed ID: 38537596
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. WTAP regulates the production of reactive oxygen species, promotes malignant progression, and is closely related to the tumor microenvironment in glioblastoma.
    Ji Q; Guo Y; Li Z; Zhang X
    Aging (Albany NY); 2024 Mar; 16(6):5601-5617. PubMed ID: 38535989
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. PDGFRA K385 mutants in myxoid glioneuronal tumors promote receptor dimerization and oncogenic signaling.
    de Villenfagne L; Sablon A; Demoulin JB
    Sci Rep; 2024 Mar; 14(1):7204. PubMed ID: 38532028
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Estrogen-receptor status determines differential regulation of α1- and α2-adrenoceptor-mediated cell survival, angiogenesis, and intracellular signaling responses in breast cancer cell lines.
    Priyanka HP; Pratap UP; Nair RS; Vasantharekha R; ThyagaRajan S
    Med Oncol; 2024 Mar; 41(5):92. PubMed ID: 38526769
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Cerebellar phenotypes in germline PTEN mutation carriers.
    Gambini D; Ferrero S; Bulfamante G; Pisani L; Corbo M; Kuhn E
    Neuropathol Appl Neurobiol; 2024 Apr; 50(2):e12970. PubMed ID: 38504418
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Hypoxia-induced TREM1 promotes mesenchymal-like states of glioma stem cells via alternatively activating tumor-associated macrophages.
    Dong M; Zhang X; Peng P; Chen Z; Zhang Y; Wan L; Xiang W; Liu G; Guo Y; Xiao Q; Wang B; Guo D; Zhu M; Yu X; Wan F
    Cancer Lett; 2024 May; 590():216801. PubMed ID: 38479552
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Discrete Mechanistic Target of Rapamycin Signaling Pathways, Stem Cells, and Therapeutic Targets.
    Jhanwar-Uniyal M; Zeller SL; Spirollari E; Das M; Hanft SJ; Gandhi CD
    Cells; 2024 Feb; 13(5):. PubMed ID: 38474373
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 125.